miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 12, 2025

Datavault AI Inc. (NASDAQ: DVLT) Mengumumkan Dewan Direksinya Menyetujui Distribusi Koin Meme Seleksi Pemain Dream Bowl kepada Seluruh Pemegang Saham Scilex Holding Company dan Datavault AI yang Memenuhi Syarat dengan Tanggal Pencatatan yang Ditetapkan pada 25 November 2025

View original at globenewswire.com
Datavault AI Inc. (NASDAQ: DVLT) Mengumumkan Dewan Direksinya Menyetujui Distribusi Koin Meme Seleksi Pemain Dream Bowl kepada Seluruh Pemegang Saham Scilex Holding Company dan Datavault AI yang Memenuhi Syarat dengan Tanggal Pencatatan yang Ditetapkan pada 25 November 2025 PHILADELPHIA, Nov…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • WiSA is the industry's first foundational wireless multi-channel and spatial HD audio transmission technology with AI covering audio timing, synchronization, and multi-channel interference cancellation.

    80% confidence
  • The commemorative token features utility including immutable proof of ownership, embedded ticket details, and exclusive content related to invited athletes, game highlights, and event access.

    80% confidence
  • Each shareholder will receive one meme coin for every common share held as of the record date of November 25, 2025.

    80% confidence
  • Short sellers are obligated to deliver the dividend meme coins to lending Datavault AI and Scilex shareholders after actual distribution by Datavault AI shortly thereafter.

    80% confidence
  • Datavault AI is a leader in data monetization technology, digital credential verification, and digital engagement.

    80% confidence
  • Short sellers of DVLT and SCLX common shares who have not closed their short positions by the ex-dividend date will be considered to have naked shorted the dividend meme coins on the record date.

    80% confidence
  • Datavault AI and Scilex remain strongly committed to creating shareholder value and continuous innovation.

    80% confidence
  • Information Data Exchange (IDE) creates Digital Twins, licensing name, image, and likeness (NIL) by securely attaching real-world objects to immutable metadata objects, fostering responsible AI with integrity.

    80% confidence
  • The company will provide further instructions regarding digital wallet setup, token access, and distribution procedures in subsequent communications before the delivery date.

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com